Neonatal group B streptococcal bacteraemia in India : ten years' experience

Group B Streptococcus (GBS) is an infrequent cause of neonatal septicaemia in many developing countries. In a perinatal centre in India with 60,119 live births between 1988 and 1997, GBS was isolated from blood cultures of 10 babies. Thus the incidence of GBS bacteraemia was 0.17 per 1000 live birth...

Full description

Saved in:
Bibliographic Details
Published in:Acta pædiatrica (Oslo) 1999-09, Vol.88 (9), p.1031-1032
Main Authors: KURUVILLA, K. A, THOMAS, N, JESUDASAN, M. V, JANA, A. K
Format: Article
Language:English
Subjects:
Bacteremia - epidemiology
Bacteremia - therapy
Bacterial diseases
Biological and medical sciences
Birth Weight
Female
Gestational Age
Human bacterial diseases
Humans
Incidence
India - epidemiology
Infant, Newborn
Infectious diseases
Male
Medical sciences
Penicillins - therapeutic use
Respiration, Artificial
Staphylococcal infections, streptococcal infections, pneumococcal infections
Streptococcal Infections - epidemiology
Streptococcal Infections - therapy
Streptococcus agalactiae - isolation & purification
Treatment Outcome
Tropical medicine
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Group B Streptococcus (GBS) is an infrequent cause of neonatal septicaemia in many developing countries. In a perinatal centre in India with 60,119 live births between 1988 and 1997, GBS was isolated from blood cultures of 10 babies. Thus the incidence of GBS bacteraemia was 0.17 per 1000 live births. Lethargy, respiratory distress and poor perfusion were the presenting features in eight symptomatic babies. Two babies had meningitis, three required ventilatory support and one died. There were no cases of late onset disease. The low incidence could be due to the low rate of colonisation and high prevalence of protective antibody in the mothers.
ISSN:0803-5253
1651-2227
DOI:10.1080/08035259950168577